用合成生物学设计多能干细胞,用于再生医学
Yihuan Mao1,2,3, Siqi Wang1,2,3, Jiazhen Yu1,2,4
1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Medical review (2021)
|April 29, 2024
概括
合成生物学为再生医学提供了对多能干细胞 (PSC) 的精确控制. 本综述探讨了合成工具,以设计PSC用于细胞治疗和有机体开发,克服当前的局限性.
科学领域:
- 干细胞生物学 干细胞生物学
- 合成生物学 合成生物学
- 再生医学是一种再生医学.
背景情况:
- 多能干细胞 (PSC) 对于再生医学至关重要,因为它们具有自我更新和分化能力.
- 目前控制干细胞行为的局限性阻碍了PSC在细胞疗法和有机体生成中的应用.
- 精确控制干细胞的命运和功能对于促进再生医学的发展至关重要.
研究的目的:
- 审查基于PSC的细胞疗法和多细胞系统生成的进展和挑战.
- 总结合成生物学工具及其在工程PSC中的应用.
- 突出合成生物学在PSC工程中用于再生医学的未来前景.
主要方法:
- 对PSC,再生医学和合成生物学现有文献的审查.
- 综合生物学工具及其在PSC工程中的具体应用.
- 对现场挑战和未来方向的分析.
主要成果:
- 合成受体和遗传电路可以实现定制的细胞反应.
- 合成生物学工具为干细胞命运决策和功能重建提供了精确的控制.
- 对于将合成生物学应用于PSC工程的治疗应用而言,存在很大的潜力.
结论:
- 合成生物学为PSCs的精确控制和工程提供了强大的工具.
- 利用合成生物学是克服基于PSC的再生医学当前局限性的关键.
- 合成生物学领域的进一步研究和开发将加速细胞治疗和有机体生成方面的进步.
相关概念视频
Induced Pluripotent Stem Cells
22.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.7K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Embryonic Stem Cells
27.3K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
27.3K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


